Clinical Trial Update: Autologous Hematopoietic Stem Cell Transplantation Combined With CD19-CART Treatment of Adult High-risk Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating autologous hematopoietic stem cell transplantation combined with CD19-CAR T-cell therapy for adult high-risk acute lymphobl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Autologous hematopoietic stem cell transplantation (Autologous hematopoietic stem cell transplantation)
• CD19 CAR-T cell therapy (CAR-T cell therapy targeting CD19)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Acute Lymphoblastic Leukemia ALL | Phase 2 | Status: RECRUITING